Nicotinamide
Nicotinamide 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Sickle Cell Disease。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
3 项
已进入 III/IV 期
10 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- EpiDestiny, Inc.
- Peking University Third Hospital
- University of Ulster
- Roskamp Institute Inc.
- St. Petersburg State Pavlov Medical University
- Fudan University
- West China Hospital
- Children's Hospital of Soochow University
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
中国、英国、美国、Russia、加拿大、法国、Ethiopia、德国、Egypt、Brazil
正在招募患者的 Nicotinamide 研究
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR
不适用招募中中国NCT06426355Adiposity and Iron Requirements in Pregnancy
不适用招募中英国NCT06425796Nicotinamide Riboside Clinical Trial for GWI
不适用招募中美国NCT05243290Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
II 期招募中RussiaNCT06532084SNF Platform Study of HR+/ HER2-advanced Breast Cancer
II 期招募中中国NCT05594095Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
II 期招募中中国NCT06482086Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
II 期招募中中国NCT06221683Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
II 期招募中美国加拿大NCT02559778Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
早期 I 期招募中美国NCT04332341Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
不适用招募中美国NCT07563322Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
不适用招募中RussiaNCT06858332Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
II 期招募中法国NCT02029001Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
不适用招募中EthiopiaNCT05708183Nicotinic Acid for the Treatment of Alzheimer's Disease
I 期 / II 期招募中美国NCT06582706Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)
II 期招募中德国NCT07286747Validation of NAD+ Measurements for Human Clinical Studies
不适用招募中美国NCT07416786Nicorandil as Anti-inflammatory in Rheumatoid Arthritis
III 期招募中EgyptNCT07516769The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients
II 期招募中EgyptNCT06640309Psilocybin Therapy in Advanced Cancer
II 期 / III 期招募中美国NCT05398484Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
II 期招募中BrazilNCT06805656Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients
I 期招募中中国NCT07119996Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
不适用招募中美国NCT06044935Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
II 期招募中美国NCT07579429Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
II 期 / III 期招募中中国NCT06972641
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。